Evidence map›Paper›PMID 41844659›Full record

ArticleNature communications2026

Isomer design unlocks rainbow phosphorescence.

Xinyue Xu, Dong Ding, Xinyu Ding, Shaoyang Han, Erkin Zakhidov, Feng Li, Mingliang Sun

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinyue XuSchool of Materials Science and Engineering, Ocean University of China, Qingdao, China.
Dong DingSchool of Materials Science and Engineering, Ocean University of China, Qingdao, China.
Xinyu DingSchool of Materials Science and Engineering, Ocean University of China, Qingdao, China.
Shaoyang HanSchool of Materials Science and Engineering, Ocean University of China, Qingdao, China.
Erkin ZakhidovInstitute of Ion-Plasma and Laser Technologies of the Academy of Sciences of the Republic of Uzbekistan, Tashkent, Uzbekistan.
Feng LiAnalytical and Testing Center, Qingdao University of Science & Technology, Qingdao, China. lifeng02@qust.edu.cn.
Mingliang SunSchool of Materials Science and Engineering, Ocean University of China, Qingdao, China. mlsun@ouc.edu.cn.ORCID http://orcid.org/0000-0002-6245-3844

Funding

National Natural Science Foundation of China (National Science Foundation of China) 52173291Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2024ME032 and ZR2024ZD15
6 · The paper itself

Abstract

Achieving predictable color-tunable organic room-temperature phosphorescence (RTP) remains challenging due to limited understanding of triplet-state regulation in heteroaromatic systems. Carbazole and benzindole isomers provide an ideal platform to clarify how nitrogen positional isomerism governs triplet exciton behavior and emission energetics. Here, we establish a unified comparative framework to systematically investigate carbazole together with Bd[f], Bd[e], and Bd[g]. Nitrogen-site modulation within the fused tricyclic skeleton generates distinct red, yellow, green, and blue phosphorescence, while mechanochemical solvent-free synthesis enables scalable preparation of previously inaccessible benzindole isomers. Photophysical measurements combined with DFT/TD-DFT calculations, single-crystal analysis, and interaction region indicator theory reveal that positional isomerism controls exciton localization, triplet stabilization, and nonradiative decay independent of the host matrix. Here, we show that isomer-regulated triplet dynamics enable full-spectrum RTP, ultralong lifetimes up to 4.23 s, TSFRET behavior, and matrix-universal multifunctionality, establishing a general molecular design principle for rainbow-like organic phosphorescent materials.

Identifiers

PMID41844659
PMCPMC13144461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.